Interestingly, a recent presentation at AACR’s Annual Meeting revealed that patients with type 2 diabetes mellitus suffering from colorectal cancer had significantly improved DFS in the presence of metformin, with tissue analysis identifying a significant reduction in tumor-associated NETs and a significant increase in CD8+ T-cells. Here, CD8A is linked to neoplasm.